Facebook
Twitter
LinkedIn
Forward
Biosimilar Operational Readiness: Managed Care Stakeholder Preparation for Market Expansion
Pricing: Free for Members and $30 for Non-Members
Course Description
With the emergence of biologics in the chronic inflammatory diseases space, all eyes are focused on the current and upcoming biosimilar pipeline. Many prominently used biologics are scheduled to lose patent protection in 2023, paving the way for a new wave of biosimilars to flood the marketplace.
It is crucial for managed care and other health professionals to monitor this unprecedented influx of biosimilars and its potential impact on pharmacy operations, patient care, and related cost savings.
This panel session will provide various managed care pharmacy perspectives on preparing for the biosimilar market expansion, including potential challenges and solutions.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Summarize the benefits and challenges of the potential biosimilar marketing expansion in 2023.
- Identify possible managed care pharmacy strategies for managing biosimilar marketing expansion including the impacts on pharmacy operations and providers.
- Describe strategies for improving education and adoption of biosimilars among key stakeholders including providers and pharmacy staff.
Faculty
Molly Borchardt, PharmD
Director, Specialty Pharmacy and Innovation
Blue Cross Blue Shield of North Carolina
Durham, NC
Kim N. Le, PharmD
Vice President, National Clinical Pharmacy Services
Kaiser Permanente
Downey, CA
Gary Rice, RPh MS MBA CSP
Senior Advisor
MedImpact Healthcare System, Inc
Fenton, MI
Moderator
Cate Lockhart, MS, PharmD, PhD
Executive Director
Biologics and Biosimilars Collective Intelligence Consortium
Alexandria, VA
Financial Relationship Disclosures
| Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
| Molly Borchardt Faculty | Disclosed no relevant financial relationships. |
| Kim Le Faculty | Disclosed no relevant financial relationships. |
Gary Rice | Employer: MedImpact |
Tracy McDowd | Disclosed no relevant financial relationships |
| Ruby Singh Planner | Disclosed no relevant financial relationships. |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-23-019-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: March 23, 2023 • Expiration Date: December 31, 2024
Activity Fee: Free for Members and $30 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP 2023. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPE
The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. - 1.25 Certificate of Completion
Price
Required Hardware/software
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities